Chemotherapy drugs made by Indian firms fail quality tests, shows study
Vital chemotherapy drugs used around the world have failed quality tests, leaving cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, the Bureau of…
Hundreds of weight loss and diabetes jab users report pancreas problems
Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes injections, prompting health officials to launch a study into side-effects. Some cases of pancreatitis…
Act on Cataract now with Next Generation Technology to keep Blindness at bay
‘See Blindness Risk off’ with ‘Centre for Sight’ Hospitals in Cataract Awareness Month New Delhi: Cataract in India is leading to blindness which can well be prevented by timely diagnosis.…
‘Stop selling, stocking, or using’: List of drugs and cosmetic banned by Karnataka
The Karnataka government has banned a total of 15 drugs and cosmetic products after they were found to be “Not of Standard Quality” by the state’s Drugs Testing Laboratory. Health…
Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details
A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after…
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg
Hyderabad: Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…
Glenmark Pharma launches TEVIMBRA in India
Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…
India’s herbal and ayurvedic OTC market set to outpace global growth
New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…
Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials
LONDON: Ananda Pharma PLC (AQSE:ANA, OTCQB: ANANF) has manufactured 40 liters of its lead investigational product MRX1 and 40 liters of matched placebo in compliance with pharmaceutical Good Manufacturing Practices…
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Hyderabad: In a ray of hope for HIV patients, particularly for the significant burden in the two-Telugu speaking States of Telangana and Andhra Pradesh, several India pharmaceutical companies have secured…
